Comparison of clinical variables and outcome of 2 natural equine herpesvirus myeloencephalopathy outbreaks induced by equine herpesvirus-1 A2254/N752 strain in sport horses
- PMID: 39778904
- PMCID: PMC11710857
- DOI: 10.1111/jvim.17287
Comparison of clinical variables and outcome of 2 natural equine herpesvirus myeloencephalopathy outbreaks induced by equine herpesvirus-1 A2254/N752 strain in sport horses
Abstract
Background: Understanding of equine herpesvirus-1 (EHV-1) myeloencephalopathy (EHM) is complicated by disparities among studies.
Objective: Compare clinical findings and outcome in horses involved in 2 recent EHM outbreaks.
Animals: Twenty-five and 10 horses affected during 2 natural EHM outbreaks were admitted to a veterinary teaching hospital (VTH) in 2021 and 2023, respectively.
Methods: Data collected from the VTH and surveys completed by riders and horse owners were analyzed retrospectively.
Results: No risk factors associated with EHM development showed significant differences between the outbreaks; both outbreaks were caused by A2254/N752 strains. Treatments administered for EHM were not significantly different, whereas the duration was longer in 2021 for flunixin meglumine (P = .01) and dimethyl sulfoxide (P < .001). In 2021, more horses required hospitalization (P = .02), and fatality rate was 32%, whereas in 2023, no patient died. Hospitalization duration was longer in 2021 than in 2023 (P = .06) and 11.7% of horses from 2021 returned to competition within 6 months, whereas 100% in 2023 did (P < .001). Ataxia grade upon admission was equivalent in 2021 and 2023, but factors related to poor prognosis, such as simultaneous development of urinary and vascular complications, occurred in 2021 but not in 2023 (P = .01).
Conclusions and clinical importance: Two EHM outbreaks caused by the A2254/N752 strain differed in disease severity. Urinary complications and systemic signs of vasculitis were important clinical variables associated with prognosis. Systemic complications in horses with EHM lead to a worse prognosis.
Keywords: EHM; neurologic; outbreak; risk factor; vaccination.
© 2025 The Author(s). Journal of Veterinary Internal Medicine published by Wiley Periodicals LLC on behalf of American College of Veterinary Internal Medicine.
Conflict of interest statement
Authors declare no conflict of interest.
Similar articles
-
Long-term performance of show-jumping horses and relationship with severity of ataxia and complications associated with myeloencephalopathy caused by equine herpes virus-1.J Vet Intern Med. 2024 May-Jun;38(3):1799-1807. doi: 10.1111/jvim.17070. Epub 2024 Apr 12. J Vet Intern Med. 2024. PMID: 38609161 Free PMC article.
-
Case-control study of a multistate equine herpesvirus myeloencephalopathy outbreak.J Vet Intern Med. 2013 Mar-Apr;27(2):339-46. doi: 10.1111/jvim.12051. Epub 2013 Feb 7. J Vet Intern Med. 2013. PMID: 23398291
-
Risk Factors and Long-Term Outcomes in Horses After the 2021 Outbreak of Equine Herpesvirus 1 Myeloencephalopathy, Valencia, Spain.J Vet Intern Med. 2025 Mar-Apr;39(2):e70040. doi: 10.1111/jvim.70040. J Vet Intern Med. 2025. PMID: 40055829 Free PMC article.
-
Equine herpesvirus 1 myeloencephalopathy.Vet Clin North Am Equine Pract. 2014 Dec;30(3):489-506. doi: 10.1016/j.cveq.2014.08.006. Epub 2014 Oct 7. Vet Clin North Am Equine Pract. 2014. PMID: 25300635 Review.
-
Equine herpesvirus-1 myeloencephalopathy: a review of recent developments.Vet J. 2009 Jun;180(3):279-89. doi: 10.1016/j.tvjl.2008.08.004. Epub 2008 Sep 19. Vet J. 2009. PMID: 18805030 Review.
Cited by
-
The Effect of Vaccination Status on Total Lymphocyte Count in Horses Affected by Equine Herpes Virus-1 Myeloencephalopathy.Animals (Basel). 2025 Apr 1;15(7):1019. doi: 10.3390/ani15071019. Animals (Basel). 2025. PMID: 40218411 Free PMC article.
References
-
- Allen GP. Epidemic disease caused by equine herpesvirus‐1: recommendations for prevention and control. Equine Vet Educ. 2002;14(3):136‐142.
-
- Ma G, Azab W, Osterrieder N. Equine herpesviruses type 1 (EHV‐1) and 4 (EHV‐4)—masters of co‐evolution and a constant threat to equids and beyond. Vet Microbiol. 2013;167(1–2):123‐134. - PubMed
-
- Pusterla N, Hussey SB, Mapes S, et al. Molecular investigation of the viral kinetics of equine herpesvirus‐1 in blood and nasal secretions of horses after corticosteroid‐induced recrudescence of latent infection. J Vet Intern Med. 2010;24(5):1153‐1157. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources